Login / Signup

Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.

Jan-Paul BohnVera ReinstadlerGeorg PallGünther StockhammerMichael SteurerHerbert OberacherDominik Wolf
Published in: European journal of drug metabolism and pharmacokinetics (2020)
Liposomal cytarabine permits prolonged CSF drug exposure, with cytotoxic cytarabine concentrations that are detectable for 4 weeks in the majority of patients. The preserved clinical activity seen in patients with inferior CSF drug concentrations (< 100 ng/ml) suggests that maintaining lower cytarabine concentrations for a longer period of time may be similarly effective as using short peak concentrations.
Keyphrases